CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

ITI Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
16.68 0.10(0.60%) NAV as on 12 Jun 2026
1.37 % 1 M
2.38 % 1 Y
19.69 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies engaged in Pharma and Healthcare.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.39

As on 30 Apr, 2026
age-icon Age :

4 yrs 7 m

Since 08 11 ,2021
exit_load Exit Load :

0.5%

aum AUM :

237.99 Crs

lock_in Lock-in :

0.50% on or before 3M, NIL after 3M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.97

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NIFTY HEALTHCARE INDEX - TRI

Fund_manager Fund Manager :

Animesh Singh,Nilay Dalal

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 1.99 %
Equity 98.01 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.25 %
Divi's Laboratories Ltd.8.43 %
Apollo Hospitals Enterprise Ltd.6.20 %
Laurus Labs Ltd.5.06 %
Torrent Pharmaceuticals Ltd.4.90 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs71.33
Hospital & Healthcare Services19.14
Plastic Products1.47
Industrial Gases & Fuels1.30
Insurance1.22
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)9.528.9413.5315.6414.73
Net Assets(Rs Crores) (as on 31-Mar-2026) 175.15 135.04 160.39 213.78 211.30
Scheme Returns(%)(Absolute)-4.83-6.0951.0514.23-4.13
B'mark Returns(%)(Absolute)NANANANANA
Category Rank74/7564/7629/9013/10271/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ITI Pharma & Healthcare Fund-Reg(G)Very HighEquity16.680.10(0.60%)NAV As on 12 Jun, 202608-Nov-2021Inception Date237.99AUM In Cr.2.38%1Y19.69%3YNA%5Y11.78%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.550.36(0.87%)NAV As on 12 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.5.40%1Y26.73%3Y15.16%5Y19.70%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity472.172.41(0.51%)NAV As on 12 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.10.66%1Y25.18%3Y15.37%5Y16.09%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.270.19(0.44%)NAV As on 12 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.11.66%1Y24.84%3Y13.91%5Y19.88%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.640.23(0.69%)NAV As on 12 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.10.62%1Y23.66%3Y12.39%5Y19.13%Since Inception